Academic Journals Database
Disseminating quality controlled scientific knowledge

Comparison of effect of simvastatin and metformin monotherapy on lipid profile and testosterone levels in polycystic ovary syndrome

ADD TO MY LIST
 
Author(s): Veena Singh | Meenakshi B. Chauhan | Meenu Deswal | Kiran Dahiya | Priya Dahiya | Ashuma Sachdeva | Ragini Singh | Rajesh Nair

Journal: Global Journal of Medicine and Public Health
ISSN 2277-9604

Volume: 1;
Issue: 3;
Date: 2012;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: Polycystic ovary syndrome | metformin | simvastatin | testosterone | lipid profile

ABSTRACT
Background: Polycystic ovary syndrome has consequences like insulin resistance, hyperandrogenism and dyslipidemia. Metformin is commonly used for treatment of this disorder and its effects on various biochemical parameters are compared with a cardioprotective drug simvastatin. Method: Fifty patients of polycystic ovary syndrome were divided into two groups depending on metformin or simvastatin administration for a period of 6 months. Levels of serun glucose, insulin, and testosterone and lipid profile were estimated before and after treatment and compared statistically for both the groups.Results: Metformin and simvastatin reduced levels of insulin and testosterone and improved lipid profile in patients of polycystic ovary disease. The effects of two groups were found to be statistically comparable. Conclusion: Efficacy of simvastatin is comparable to metformin for treatment of polycystic ovary syndrome, though more studies are required to support this view.
Save time & money - Smart Internet Solutions     

Tango Rapperswil
Tango Rapperswil